New insider activity at Kewaunee Scientific ( (KEQU) ) has taken place on September 24, 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
President & CEO Thomas David III Hull has recently sold 1,721 shares of Kewaunee Scientific stock, amounting to a total sale value of $75,344.
Recent Updates on KEQU stock
Kewaunee Scientific has recently made significant strides with the appointment of J. Jette Campbell to its Board of Directors, aiming to leverage his expertise in financial restructuring and business strategy to accelerate growth and expand its global presence. The company reported strong Q1 revenue growth, increasing from $48.3M to $71.1M year-over-year, despite facing challenging market conditions due to uncertain government policies and evolving tariff structures. CEO Thomas Hull III highlighted the company’s focus on strategic investments to support sustainable growth, although these investments may pressure near-term earnings. Analysts have maintained a positive outlook on KEQU, citing strong financial performance and operational efficiency as key factors. However, they caution about potential corrections due to technical indicators, despite the stock’s bullish momentum.
Spark’s Take on KEQU Stock
According to Spark, TipRanks’ AI Analyst, KEQU is a Neutral.
Kewaunee Scientific’s overall stock score is primarily influenced by its solid financial performance, which is offset by bearish technical indicators. The stock’s undervaluation offers potential upside, but the lack of dividend yield and negative market momentum are significant concerns.
To see Spark’s full report on KEQU stock, click here.
More about Kewaunee Scientific
YTD Price Performance: -30.62%
Average Trading Volume: 14,311
Technical Sentiment Signal: Hold
Current Market Cap: $126.1M